← Back to Search

Ageless Grace for Stroke (CAPS Trial)

N/A
Recruiting
Led By greg thielman, EdD
Research Sponsored by Saint Joseph's University, Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects who have sustained a stroke and are over 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up effects of a 3 day baseline walking average (prior to the 24 sessions at 2x/wk) compared to a 3 day walking average post training
Awards & highlights

CAPS Trial Summary

This trial will measure walking, balance, and thinking abilities of participants by having them complete tasks while standing, walking, and carrying objects. They will also answer health questions.

Who is the study for?
This trial is for adults over 18 who have had a stroke at least 3 months ago and can walk unassisted. It's also open to healthy, retired or semi-retired older adults able to exercise safely in a seated group setting as confirmed by their doctor. Participants must be able to follow instructions and communicate with researchers.Check my eligibility
What is being tested?
The study tests 'Ageless Grace', a program designed to improve cognitive function and motor skills after neurotrauma like stroke. Participants will perform various physical tasks while simultaneously engaging in cognitive challenges, such as counting or naming objects.See study design
What are the potential side effects?
Since the intervention involves physical activity, potential side effects may include muscle soreness, fatigue, or minor injuries related to exercise. However, participants are screened for safety to minimize risks.

CAPS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and have had a stroke.

CAPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~effects of a 3 day baseline walking average (prior to the 24 sessions at 2x/wk) compared to a 3 day walking average post training
This trial's timeline: 3 weeks for screening, Varies for treatment, and effects of a 3 day baseline walking average (prior to the 24 sessions at 2x/wk) compared to a 3 day walking average post training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Differences in cognitive and motor function in individuals post stroke compared to age matched older adults measured by time differential between various walking distances and these tasks with a cognitive activity challenge included.
Differences in cognitive and motor function in individuals post stroke compared to age matched older adults will be measured by time differential between isolated motor tasks (number of sit to stands) and task with cognitive activity challenge.
Differences in cognitive and motor function measured by time differential between isolated motor tasks (number of seated alternative limb marches) and tasks that include a cognitive activity challenge as well.
Secondary outcome measures
Walking monitors measurement

CAPS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Subject's Post StrokeExperimental Treatment1 Intervention
Individuals post stroke have recently participated in this ongoing investigation in a live format but these subjects are now entered into a telehealth arm. In the future others will participate in the live format
Group II: Healthy Older AdultsActive Control1 Intervention
This subset of subject's have a fair history with this methodology and are being used as the comparator. Age matched older adults

Find a Location

Who is running the clinical trial?

Saint Joseph's University, PhiladelphiaLead Sponsor
2 Previous Clinical Trials
190 Total Patients Enrolled
greg thielman, EdDPrincipal InvestigatorSaint Joseph's University

Media Library

Subject's Post Stroke Clinical Trial Eligibility Overview. Trial Name: NCT05919251 — N/A
Stroke Research Study Groups: Healthy Older Adults, Subject's Post Stroke
Stroke Clinical Trial 2023: Subject's Post Stroke Highlights & Side Effects. Trial Name: NCT05919251 — N/A
Subject's Post Stroke 2023 Treatment Timeline for Medical Study. Trial Name: NCT05919251 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation still recruiting participants?

"This study, which was first publicized on June 1st 2020, is actively searching for subjects. The trial's page on clinicaltrials.gov has been edited as recently as 15th of June 2023."

Answered by AI

How many participants are participating in this experiment?

"Affirmative, according to the information on clinicaltrials.gov this clinical trial is in need of participants. It was initially listed June 1st 2020 and amended most recently on June 15th 2023. Thirty individuals must be recruited from a single site for the experiment's completion."

Answered by AI
~2 spots leftby Aug 2024